Source: Annual Congress 2003 - Markers, mediators and mechanisms of human lung injury
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Hataji, E. C. Gabazza, Y. Nishii, C. N. D'Alessandro-Gabazza, T. Yoshida, Y. Adachi, O. Taguchi (Tsu, Japan). Correlation between tenascin C and tissue factor in patients with interstitial lung disease. Eur Respir J 2003; 22: Suppl. 45, 615

Member's Comments

No comment yet.

Related content which might interest you: B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004 Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Increased cytokeratin-19 expression in fibrotic interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Significance of protein S in patients with interstitial lung disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 A clinicopathological review of interstitial pneumonia with marked IgG4 positive plasma cells infiltration Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies Source: International Congress 2016 – Connective tissue disorders Year: 2016 Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests Source: Eur Respir J 2002; 20: Suppl. 38, 106s Year: 2002 Elevation of serum tumor markers in patients with interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis Source: International Congress 2016 – Connective tissue disorders Year: 2016 The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease Source: Eur Respir J, 58 (6) 2101560; 10.1183/13993003.01560-2021 Year: 2021 Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy}, Source: Eur Respir J 2012; 40: 641-648 Year: 2012 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Expression of TGF-β1 and TGFβ receptors in lung tissue of patients with idiopathic interstitial pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 TNFα and INFγ inducing capacity of sera from interstitial lung diseases (ILD) patients in relation to its angiogenic activity Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001 Transforming growth factor B1 polymorphism and serum levels in interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015